• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


lannett

  1. Thalomid - Confidential settlement with Lannett

    http://alph.st/b9f74234 Remember, Celgene settled a lawsuit for the fraudulent use of Thalomid in July 2017 for $280 million. Now Lannett is going to manufacture the generic version of Thalomid.
    • anonymous
    • Thread
    • agreement cancer treatment celgene lannett settlement
    • Replies: 0
    • Forum: Celgene

  2. Lannett's CEO?

    Thoughts on why Bedrosian is being replaced?
    • anonymous
    • Thread
    • lannett
    • Replies: 0
    • Forum: Lannett
Top Bottom
Back